This action promotes HCC progression and immune evasion, primarily by inhibiting the cytotoxic activity of CD8+ T cells, and the process is conditionally dependent on Hu antigen R (HuR) (45). This evidence concerns the gene ELAVL1 and hepatocellular carcinoma.